Ping An Biomedical (PASW) Accumulated Expenses (2024 - 2025)
Ping An Biomedical (PASW) reported Accumulated Expenses of $6532.0 for Q3 2025, up 164.64% on a YoY basis from $2468.3 in Q3 2024, and up 164.64% quarter-over-quarter from $2468.3 in Q3 2024.
Ping An Biomedical (PASW) Accumulated Expenses (2024 - 2025) Analysis & Trends
Ping An Biomedical has reported Accumulated Expenses for 2 years, with the latest figure at $6532.0 in Q3 2025.
- For the quarter ending Q3 2025, Accumulated Expenses rose 164.64% year-over-year to $6532.0; the trailing twelve-month figure through Sep 2025 stood at $6532.0 (up 164.64% YoY), and the FY2025 full-year result was $6567.0, up 166.06% from the prior year.
- Accumulated Expenses for Q3 2025 stood at $6532.0, up from $2468.3 in the prior quarter.
- The five-year high for Accumulated Expenses was $6532.0 in Q3 2025, with the low at $2468.3 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Albany International | 1.99 Bn | 1.87 Bn | 99.79 Mn |
| 2 | Unifi | 73.82 Mn | 45.35 Mn | 9.12 Mn |
| 3 | Ping An Biomedical | 427,306.12 | -4.70 Mn | - |
| 4 | Culp | - | - | 5.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6,531.95 |
| Sep 30, 2024 | 2,468.28 |